Navigation Links
Yongye International Announces First Quarter 2010 Results
Date:5/12/2010

sales, in the same period last year. The increase in margin was primarily due to additional expenses related to advertising and promotional activities and, to a lesser extent, increases in freight expenses, salaries, professional fees and travel expenses. Operating income was $5.6 million compared to $3.3 million in the same period last year.

Net income was $4.4 million, or $0.10 per diluted share, in the first quarter of 2010, compared to net income of $3.3 million, or $0.12 per diluted share, in the first quarter of 2009. The Company recorded a non-cash change in fair value of derivative liabilities of $12,534 in the first quarter of 2010. Excluding the impact of this non-cash item, adjusted net income was $4.4 million, or $0.10 per diluted share, compared to adjusted net income of $3.1 million, or $0.12 per diluted share in the same period last year.(*)

    (*) See the table following this press release for a reconciliation of net
        income and diluted EPS to exclude the non-cash change in fair value of
        derivative liabilities.

Financial Condition

As of March 31, 2010, the Company had $51.0 million in cash, compared to $65.5 million as of December 31, 2009. Working capital was $98.9 million, compared to $107.7 million at the end of 2009. As of year-end 2009, the Company had only $0.5 million in long
'/>"/>

SOURCE Yongye International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Yongye International Announces Conference Call to Discuss First Quarter Fiscal Year 2010 Results
2. Yongye International to Present at Upcoming Investor Conferences
3. Yongye International, Inc. Begins Construction of New Production Facility
4. Yongye International Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2009 Results
5. Yongye International Announces Conference Call to Discuss Third Quarter 2009 Results
6. Yongye International Announces 2010-2012 Strategic Plan
7. Yongye International Announces Expansion of Research and Development Center
8. Yongye International Announces Branded Store Network Increases Over 40% to 5,000 Stores
9. Yongye Biotechnology International Receives License to Manufacture Products
10. Yongye Biotechnology International Raises $ 9.0 Million In Private Placement, Raises Guidance
11. Yongye Biotechnology Distributor has Record Breaking Single Store Sales Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... SEATTLE , April 1, 2015  Adaptive ... The Lancet Oncology showing ... the company,s next-generation sequencing-based minimal residual disease (MRD) ... clonoSEQ™ MRD test) accurately identifies patients with diffuse ... of relapse after initial treatment, usually several months ...
(Date:4/1/2015)... 01, 2015 Park Systems, ... selected to receive the prestigious “Best Analytic Instrumentation ... NX10 is the premium research-grade True Non-Contact AFM, ... linearity, closed-loop detector noise, and minimized thermal drift. ... n, which allows images with a single click, ...
(Date:4/1/2015)... TORONTO , April 1, 2015 /PRNewswire/ - ... Securities Exchange: PBT.U), is pleased to announce that ... holds 54% equity, has entered into an agreement ... Biohaven,s first clinical trial with their lead compound ... the identification and development of clinical stage neuroscience ...
(Date:4/1/2015)... , April 1, 2015  Among 1,050 U.S. consumers, ... oral cancer (68 percent) and only 36 percent reported ... check-up, according to findings from a survey ... leading innovator and developer of solutions that aid in ... The online survey polled 1,050 U.S. consumers on their ...
Breaking Biology Technology:Adaptive Biotechnologies' clonoSEQ Minimal Residual Disease Test Predicts Relapse in Diffuse Large B-Cell Lymphoma Patients by Sensitively Detecting Circulating Tumor DNA 2Adaptive Biotechnologies' clonoSEQ Minimal Residual Disease Test Predicts Relapse in Diffuse Large B-Cell Lymphoma Patients by Sensitively Detecting Circulating Tumor DNA 3Adaptive Biotechnologies' clonoSEQ Minimal Residual Disease Test Predicts Relapse in Diffuse Large B-Cell Lymphoma Patients by Sensitively Detecting Circulating Tumor DNA 4Adaptive Biotechnologies' clonoSEQ Minimal Residual Disease Test Predicts Relapse in Diffuse Large B-Cell Lymphoma Patients by Sensitively Detecting Circulating Tumor DNA 5Park Systems Awarded the New Economy Magazine “Best Analytic Instrumentation Company 2014” 2Portage's Biohaven Announces Agreement with inVentiv Health 2Portage's Biohaven Announces Agreement with inVentiv Health 3National Oral Cancer Awareness Survey Reveals Greater Need for Education and Screening Tools for Oral Cancer Among U.S. Adults 2National Oral Cancer Awareness Survey Reveals Greater Need for Education and Screening Tools for Oral Cancer Among U.S. Adults 3National Oral Cancer Awareness Survey Reveals Greater Need for Education and Screening Tools for Oral Cancer Among U.S. Adults 4
... - Merge Healthcare has released a new ... to enhance the image reading capabilities of radiologists. , ... Mammo(TM) version 7.0, will make possible simultaneous display and ... digital mammography, regardless of which vendor's acquisition device is ...
... the chance to play a bit more with the independent ... conference, Jaman.com offers a growing library of films to rent ... $6 per film. , ,While you can browse the Web ... downloadable player, a desktop application that's part media player, part ...
... Waukesha, Wis. - GE Healthcare has ... Research Excellence in Breast Cancer Imaging within the ... , ,With funding from GE Healthcare, a $17 billion ... is designed to advance and commercialize research and technology ...
Cached Biology Technology:We're "Jaman": Purpose-driven browsers drive next wave of Web applications 2We're "Jaman": Purpose-driven browsers drive next wave of Web applications 3
(Date:3/12/2015)... 12, 2015 WHEN:Tuesday, March 17, 2015 at ... http://bit.ly/1G7Os0L . SPEAKERS: , Frost & Sullivan Measurement ... http://photos.prnewswire.com/prnh/20150311/181111 Biometric companies must plan ... several different markets and industries. This is especially ... uptrend. Join Frost & Sullivan,s ...
(Date:3/10/2015)... 2015  Continuing its 167-year history of offering the ... The Eye Scanning Password Authenticator , a device ... secure websites or sensitive data. Employing the ... borders, the device has a small camera that scans ... iris, converting them into an encrypted ID that cannot ...
(Date:3/10/2015)... , March 10, 2015  NXT-ID, Inc. ... or the "Company"), a biometric authentication company focused ... company,s Wocket™ smart wallet has been named the ... Rethink Modern. Rethink Modern ( http://www.rethinkmodern.com/ ... innovative items for your home and lifestyle that have a ...
Breaking Biology News(10 mins):Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 2Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 3Hammacher Schlemmer Introduces The Eye Scanning Password Authenticator 2NXT-ID's Wocket Smart Wallet Named Number One Best Tech Gift for 2015 by Rethink Modern 2NXT-ID's Wocket Smart Wallet Named Number One Best Tech Gift for 2015 by Rethink Modern 3NXT-ID's Wocket Smart Wallet Named Number One Best Tech Gift for 2015 by Rethink Modern 4
... 2007) -- A research team at Weill Cornell Medical College ... be crucial to the production of an immune system cytokine ... an important "missing link" in a biochemical pathway that,s long ... diabetes, to cancer and AIDS. "IL-10 production has to ...
... NewYork-Presbyterian/Weill Cornell,s Dr. Jeffrey Borer Emphasize Need for ... Studies and Continuing Past Drug Approval NEW ... should be strengthened to ensure acceptable cardiovascular safety ... according to a recent presentation made by Dr. ...
... other studies linking human DNA to that of primates, there ... of evolution in DNA. Professor and research geneticist Daniel J. ... in the DNA of every person on the planet in ... DNA (Prometheus Books, $24.95). This book comes at a ...
Cached Biology News:2 genes are important key to regulating immune response 22 genes are important key to regulating immune response 3Physician-scientist urges improved drug regulation to ensure heart safety of non-heart drugs 2Physician-scientist urges improved drug regulation to ensure heart safety of non-heart drugs 3There is powerful evidence of evolution in human DNA 2
MAb to Yersinia pestis F1 Ag. Yersinia pestis F1 Antigen EB Strain...
...
... The Dodeca silver stain kits are ... devices including Bio-Rad Dodeca stainers. This ... quantities of proteins in polyacrylamide gels ... kit includes sensitizer concentrate, silver reagent ...
... thermal cycler holds 96 x 0.2 ml ... heated lid incorporates a thumbwheel to adjust ... vessels for oil-free cycling. Peltier heat pumps ... and ramping rates of up to 1.4 ...
Biology Products: